Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Effect of store and forward teledermatology on quality of life: a randomized controlled trial.

Whited JD, Warshaw EM, Edison KE, Kapur K, Thottapurathu L, Raju S, Cook B, Engasser H, Pullen S, Parks P, Sindowski T, Motyka D, Brown R, Moritz TE, Datta SK, Chren MM, Marty L, Reda DJ.

JAMA Dermatol. 2013 May;149(5):584-91. doi: 10.1001/2013.jamadermatol.380.

3.

Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.

Brundage M, Blazeby J, Revicki D, Bass B, de Vet H, Duffy H, Efficace F, King M, Lam CL, Moher D, Scott J, Sloan J, Snyder C, Yount S, Calvert M.

Qual Life Res. 2013 Aug;22(6):1161-75. doi: 10.1007/s11136-012-0252-1. Epub 2012 Sep 18. Review.

4.

Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).

Duckworth KE, McQuellon RP, Russell GB, Cashwell CS, Shen P, Stewart JH 4th, Levine EA.

J Surg Oncol. 2012 Sep 15;106(4):376-80. doi: 10.1002/jso.23089. Epub 2012 Mar 22.

5.

Health-related quality of life as an outcome variable in Parkinson's disease.

Martinez-Martin P, Kurtis MM.

Ther Adv Neurol Disord. 2012 Mar;5(2):105-17. doi: 10.1177/1756285611431974.

6.

Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.

Hamidou Z, Dabakuyo TS, Mercier M, Fraisse J, Causeret S, Tixier H, Padeano MM, Loustalot C, Cuisenier J, Sauzedde JM, Smail M, Combier JP, Chevillote P, Rosburger C, Arveux P, Bonnetain F.

Oncologist. 2011;16(10):1458-68. doi: 10.1634/theoncologist.2011-0085. Epub 2011 Sep 23.

7.

Reporting on quality of life in randomised controlled trials in gastrointestinal surgery.

Bridoux V, Moutel G, Lefebure B, Scotte M, Michot F, Herve C, Tuech JJ.

J Gastrointest Surg. 2010 Jan;14(1):156-65. doi: 10.1007/s11605-009-1052-y. Epub 2009 Oct 14.

8.

A short functional survey is responsive to changes in functional status in vulnerable older people.

Min LC, Wenger NS, Reuben DB, Saliba D.

J Am Geriatr Soc. 2008 Oct;56(10):1932-6. doi: 10.1111/j.1532-5415.2008.01921.x. Epub 2008 Sep 4.

9.

Psychometric characteristics of the Spanish version of instruments to measure neck pain disability.

Kovacs FM, Bagó J, Royuela A, Seco J, Giménez S, Muriel A, Abraira V, Martín JL, Peña JL, Gestoso M, Mufraggi N, Núñez M, Corcoll J, Gómez-Ochoa I, Ramírez MJ, Calvo E, Castillo MD, Martí D, Fuster S, Fernández C, Gimeno N, Carballo A, Milán A, Vázquez D, Cañellas M, Blanco R, Brieva P, Rueda MT, Alvarez L, Del Real MT, Ayerbe J, González L, Ginel L, Ortega M, Bernal M, Bolado G, Vidal A, Ausín A, Ramón D, Mir MA, Tomás M, Zamora J, Cano A.

BMC Musculoskelet Disord. 2008 Apr 9;9:42. doi: 10.1186/1471-2474-9-42.

10.

Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study.

Korfage IJ, de Koning HJ, Essink-Bot ML.

Qual Life Res. 2007 Dec;16(10):1627-34. Epub 2007 Oct 5.

11.

Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index.

Harding G, Cella D, Robinson D Jr, Mahadevia PJ, Clark J, Revicki DA.

Health Qual Life Outcomes. 2007 Jun 14;5:34.

12.

Responsiveness and minimal important differences for patient reported outcomes.

Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK.

Health Qual Life Outcomes. 2006 Sep 27;4:70.

13.

Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.

Matza LS, Buchanan R, Purdon S, Brewster-Jordan J, Zhao Y, Revicki DA.

Schizophr Bull. 2006 Oct;32(4):666-78. Epub 2006 Jul 7. Review.

14.

The measurement of response shift in patients with advanced prostate cancer and their partners.

Rees J, Clarke MG, Waldron D, O'Boyle C, Ewings P, MacDonagh RP.

Health Qual Life Outcomes. 2005 Mar 30;3:21.

15.
16.

Supplemental Content

Support Center